Text Size
6026 studies found for:    eye

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients
Condition: Eye Drops Self-instillation
Interventions: Device: Eye Drop Guide technique;   Behavioral: Routine self-instillation technique
2 Completed
Has Results 		A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: CP-690,550 Eye drops;   Drug: CP-690,550 Eye drops-vehicle;   Drug: Sodium Hyaluronate
3 Completed Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye
Condition: Dry Eye
Interventions: Drug: Dexamethasone phosphate ophthalmic solution;   Drug: Sodium citrate buffer solution
4 Completed
Has Results 		Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
Conditions: Dry Eye Syndrome;   Dry Eye
Interventions: Drug: Thymosin beta 4;   Drug: Placebo
5 Completed Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: 0.3% BOL-303242-X ophthalmic suspension;   Drug: 2% BOL-303242-X ophthalmic suspension;   Drug: Placebo Comparator: Vehicle;   Drug: 1% BOL-303242-X ophthalmic suspension;   Drug: 2% BOL-303242-X ophthalmic suspension AM;   Drug: 2% BOL-303242-X ophthalmic suspension PM
6 Completed Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program
Conditions: Eye Disease;   Eye Care;   Vision
Interventions: Behavioral: Eye care education;   Behavioral: Social-contact control
7 Completed
Has Results 		Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: Carboxymethylcellulose Based Eye Drop Formulation A;   Drug: Carboxymethylcellulose Based Eye Drop Formulation B;   Drug: Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops;   Drug: Carboxymethylcellulose Based Lubricant Eye Drops
8 Recruiting Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
Condition: Dry Eye Syndromes
Intervention: Drug: Cyclosporine ophthalmic solution
9 Completed Moisture Chamber Glasses for Dry Eye in Asian Population
Condition: Dry Eye
Intervention: Device: 7eye( Panoptx)™ moisture chamber glasses
10 Completed Safety Evaluation of a New Preservative in a Lubricating Eye Drop
Condition: Dry Eye Syndromes
Intervention: Other: Eye Drops with Experimental Preservative
11 Completed Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: rebamipide 2% ophthalmic suspension;   Drug: placebo eye drops
12 Completed Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Condition: Dry Eye
Interventions: Drug: DE-101 ophthalmic suspension;   Drug: DE-101 ophthalmic suspension vehicle
13 Recruiting Canadian Eye Injury Registry
Condition: Eye Injuries
Intervention: Behavioral: Public Health strategies
14 Active, not recruiting Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
Conditions: Dry Eyes;   Allergic Conjunctivitis
Intervention:
15 Completed Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
Condition: Dry Eye Syndrome
Interventions: Drug: EGP-437 with EyeGate® II System;   Drug: Sodium citrate buffer solution with EyeGate® II System
16 Recruiting Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
Conditions: Dry Eye;   Sjogren's Syndrome;   Graft vs. Host Disease
Intervention: Drug: Thymosin Beta 4 eye drops vs. vehicle
17 Completed Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
Conditions: Ocular Dryness;   Ocular Irritation;   Open-Angle Glaucoma;   Ocular Hypertension
Intervention: Drug: Travaprost without BAC (Travatan Z)
18 Completed
Has Results 		Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: cyclosporine ophthalmic emulsion Formulation A;   Drug: cyclosporine ophthalmic emulsion Formulation B;   Drug: cyclosporine ophthalmic emulsion Formulation A; cyclosporine ophthalmic emulsion 0.05%;   Drug: cyclosporine ophthalmic emulsion Formulation B; cyclosporine ophthalmic emulsion 0.05%;   Drug: cyclosporine ophthalmic emulsion Formulation A; cyclosporine ophthalmic emulsion Formulation B
19 Completed Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
Condition: Dry Eye
Interventions: Drug: cis-urocanic acid 0,5% eye drops;   Drug: cis-urocanic acid 2.5% eye drops;   Drug: Placebo for cis-UCA, eye drops
20 Completed
Has Results 		Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: bimatoprost /timolol formulation A fixed combination ophthalmic solution;   Drug: bimatoprost/timolol fixed combination ophthalmic solution
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years